The FDA is implementing stricter approval standards for COVID-19 vaccines, focusing on high-risk groups, including individuals over 65 and those with medical conditions. This shift comes as the Trump administration announces plans to stop recommending routine vaccines for healthy adults, children, and pregnant women. As a result of these developments, access to COVID vaccines is being limited, which has sparked significant discussion regarding the future of vaccination policies. Additionally, annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved, reflecting a major change in public health guidelines.